Plexus (NASDAQ:PLXS) CFO Patrick John Jermain Sells 4,841 Shares

Plexus Corp. (NASDAQ:PLXSGet Free Report) CFO Patrick John Jermain sold 4,841 shares of the firm’s stock in a transaction that occurred on Tuesday, February 3rd. The stock was sold at an average price of $204.01, for a total transaction of $987,612.41. Following the sale, the chief financial officer owned 20,469 shares in the company, valued at approximately $4,175,880.69. This trade represents a 19.13% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Patrick John Jermain also recently made the following trade(s):

  • On Tuesday, November 11th, Patrick John Jermain sold 2,000 shares of Plexus stock. The shares were sold at an average price of $143.53, for a total value of $287,060.00.

Plexus Trading Down 0.6%

Shares of Plexus stock traded down $1.18 during trading hours on Tuesday, reaching $203.78. 467,844 shares of the company’s stock were exchanged, compared to its average volume of 336,447. The firm has a market capitalization of $5.45 billion, a price-to-earnings ratio of 31.69 and a beta of 0.81. The company has a current ratio of 1.59, a quick ratio of 0.75 and a debt-to-equity ratio of 0.06. Plexus Corp. has a 52-week low of $103.43 and a 52-week high of $208.92. The company has a fifty day moving average of $161.31 and a 200-day moving average of $146.47.

Plexus (NASDAQ:PLXSGet Free Report) last released its earnings results on Wednesday, January 28th. The technology company reported $1.78 earnings per share for the quarter, topping the consensus estimate of $1.77 by $0.01. Plexus had a return on equity of 12.39% and a net margin of 4.28%.The firm had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.07 billion. During the same period in the prior year, the business posted $1.73 earnings per share. The firm’s revenue for the quarter was up 9.6% compared to the same quarter last year. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. Sell-side analysts forecast that Plexus Corp. will post 5.9 EPS for the current fiscal year.

Institutional Investors Weigh In On Plexus

A number of large investors have recently added to or reduced their stakes in PLXS. American Century Companies Inc. lifted its holdings in Plexus by 44.2% in the 3rd quarter. American Century Companies Inc. now owns 1,103,892 shares of the technology company’s stock worth $159,722,000 after buying an additional 338,119 shares in the last quarter. Balyasny Asset Management L.P. acquired a new position in shares of Plexus in the third quarter worth about $12,509,000. Arrowstreet Capital Limited Partnership increased its holdings in Plexus by 965.0% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 80,890 shares of the technology company’s stock worth $11,704,000 after purchasing an additional 73,295 shares during the last quarter. Qube Research & Technologies Ltd raised its position in shares of Plexus by 37.1% in the 2nd quarter. Qube Research & Technologies Ltd now owns 242,726 shares of the technology company’s stock valued at $32,843,000 after purchasing an additional 65,644 shares in the last quarter. Finally, Bank of America Corp DE boosted its stake in shares of Plexus by 53.6% during the 2nd quarter. Bank of America Corp DE now owns 177,237 shares of the technology company’s stock valued at $23,982,000 after buying an additional 61,817 shares during the last quarter. 94.45% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on the stock. Weiss Ratings reissued a “hold (c+)” rating on shares of Plexus in a research note on Thursday, January 22nd. Wall Street Zen downgraded Plexus from a “buy” rating to a “hold” rating in a report on Saturday, November 22nd. Sidoti cut Plexus from a “buy” rating to a “neutral” rating and set a $150.00 target price for the company. in a report on Friday, October 24th. Stifel Nicolaus increased their target price on shares of Plexus from $150.00 to $200.00 and gave the stock a “hold” rating in a research report on Friday. Finally, Needham & Company LLC lifted their price target on shares of Plexus from $165.00 to $206.00 and gave the company a “buy” rating in a research report on Friday. Two research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $189.20.

Get Our Latest Report on PLXS

Plexus Company Profile

(Get Free Report)

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.

Featured Articles

Insider Buying and Selling by Quarter for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.